mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.25 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |